{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T20:42:03Z","timestamp":1789591323607,"version":"build-2803163510"},"reference-count":29,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2008,6,28]],"date-time":"2008-06-28T00:00:00Z","timestamp":1214611200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropathology Appl Neurobio"],"published-print":{"date-parts":[[2009,2]]},"abstract":"<jats:p> <jats:bold>Aims:<\/jats:bold> We compared myopathological features in myasthenia gravis (MG) patients with antibodies against AChR (seropositive) and muscle\u2010specific tyrosin\u2010kinase (MuSK). While the immunopathogenesis of seropositive MG is well known, there is a lack of pathological studies in anti\u2010MuSK antibody\u2010positive (MuSK+) MG. <jats:bold>Methods:<\/jats:bold> We analysed skeletal muscle biopsy features of 13 MG patients: 6 MuSK+ (all women) and 7 anti\u2010AchR antibody\u2010positive (AChR+) (2 women and 5 men). In our histopathological examination, we quantified the atrophy factor of both fibre types, and the extent of minicores, myofibrillar disarray, cytochrome c oxidase (COX)\u2010negative fibres, mitochondrial aggregates and fibre type grouping. <jats:bold>Results:<\/jats:bold> Mean muscle fibre atrophy factor was higher in AChR+ MG than MuSK+ MG, both in type I fibres (494 <jats:italic>vs.<\/jats:italic> 210) and particularly in type II fibres (1023 <jats:italic>vs.<\/jats:italic> 300). Fibre type grouping was observed in AChR+ MG whereas COX\u2010negative fibres were common in MuSK+ MG. Bulbar muscles were more severely affected in MuSK+ MG and the disease was more severe: the onset was usually earlier (39 years) with Myasthenia Gravis Foundation of America score III in MuSK+ MG, and score II was found in AChR+ MG (62 years). <jats:bold>Conclusions:<\/jats:bold> Muscle biopsies of MuSK+ MG show myopathic signs with prominent mitochondrial abnormalities, whereas neurogenic features and atrophy are more frequently found in AChR+ MG. The mitochondrial impairment could explain the oculo\u2010bulbar involvement in MuSK+ MG.<\/jats:p>","DOI":"10.1111\/j.1365-2990.2008.00965.x","type":"journal-article","created":{"date-parts":[[2008,6,19]],"date-time":"2008-06-19T10:09:43Z","timestamp":1213870183000},"page":"103-110","source":"Crossref","is-referenced-by-count":61,"title":["Muscle histopathology in myasthenia gravis with antibodies against MuSK and AChR"],"prefix":"10.1111","volume":"35","author":[{"given":"S.","family":"Martignago","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Fanin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Albertini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Pegoraro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Angelini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,1,21]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)81251-9"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1038\/85520"},{"key":"e_1_2_5_4_2","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jneuroim.2005.08.016","article-title":"MuSK antibody positive myasthenia gravis plasma modifies MURF\u20101 expression in C2C12 cultures and mouse muscles in vivo","volume":"120","author":"Benveniste O","year":"2005","journal-title":"J Neuroimmunol"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.20061"},{"key":"e_1_2_5_6_2","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jneuroim.2007.01.010","article-title":"Effect of sera from AChR\u2010antibody negative myasthenia gravis patients on AChR and MuSK in cell cultures","volume":"185","author":"Farrugia ME","year":"2007","journal-title":"J Neuroimmunol"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000228225.23349.5d"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinph.2005.06.003"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2004.052415"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awg223"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.62.6.1002"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00115-003-1672-5"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.wco.0000180660.57801.3f"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(03)00306-5"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2006.09.022"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000254620.45529.97"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2005.01137.x"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.55.1.16"},{"key":"e_1_2_5_19_2","first-page":"612","volume-title":"Muscle Biopsy, A Practical Approach","author":"Dubowitz V.","year":"1985"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0891-5849(01)00517-2"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00687070"},{"key":"e_1_2_5_22_2","unstructured":"AngeliniC.Miastenia gravis. InProgressi Clinici in Medicina. Padova:Piccin 1994; Vol.2\u2010n. 1 209\u2013220."},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinph.2006.03.028"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199406233302507"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/mus.20030"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.74.5.2130"},{"key":"e_1_2_5_27_2","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S0140-6736(86)92259-2","article-title":"Myasthenia gravis without acetylcholine receptor antibody: a distinct disease entity","volume":"1","author":"Mossman S","year":"1986","journal-title":"Lancet"},{"key":"e_1_2_5_28_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000065882.63904.53"},{"key":"e_1_2_5_29_2","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1405.021"},{"key":"e_1_2_5_30_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0404.2006.00649.x"}],"container-title":["Neuropathology and Applied Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2990.2008.00965.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2990.2008.00965.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T23:21:07Z","timestamp":1695943267000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2990.2008.00965.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1,21]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["10.1111\/j.1365-2990.2008.00965.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2990.2008.00965.x","archive":["Portico"],"relation":{},"ISSN":["0305-1846","1365-2990"],"issn-type":[{"value":"0305-1846","type":"print"},{"value":"1365-2990","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,1,21]]}}}